Increased cancer risk for kidney transplant recipients linked to Epstein-Barr virus Image: iStock/peterschreiber.media Increased cancer risk for kidney transplant recipients linked to Epstein-Barr virus Researchers suggest changes in kidney transplant care and monitoring.
With hemophilia B, a lifetime of worry eased with one infusion Image: iStock/Isaac Lee With hemophilia B, a lifetime of worry eased with one infusion The first Penn Medicine patient to receive an FDA-approved new gene therapy for hemophilia B can now stop regular prophylactic clotting factor injections.
Pursuing vaccines to stop celiac disease Image: iStock/nuttapong punna Pursuing vaccines to stop celiac disease Scientists at Penn’s Institute for RNA Innovation are using messenger RNA to stop the immune response that triggers celiac disease symptoms.
Researchers create genetic map tied to kidney disease Image: iStock/TanyaJoy Researchers create genetic map tied to kidney disease The creation of the most complete map of more than 1,000 genes that influence kidney function could help experts diagnose and design targeted treatments for kidney disease.
Rate of suicide higher in individuals with headaches Image: iStock/Ake Ngiamsanguan Rate of suicide higher in individuals with headaches New research from Penn Medicine finds that suicide attempt and completion is highest among individuals with headaches from head injuries, but also elevated in individuals with mild headaches.
Catherine and Anthony Clifton make transformational gift to accelerate patient care, research, and education at Penn Medicine From left to right, Penn Medicine Board Chair Dhan Pai; Interim Penn President J. Larry Jameson; donors Catherine and Anthony Clifton; Hospital of the University of Pennsylvania CEO Regina Cunningham; University of Pennsylvania Health System CEO Kevin B. Mahoney; and Interim EVP of the University for the Health System and Perelman School of Medicine Dean Jonathan A. Epstein.(Image: Eddy Marenco) Catherine and Anthony Clifton make transformational gift to accelerate patient care, research, and education at Penn Medicine The Pavilion will be renamed in recognition of the Cliftons’ historic philanthropic commitment, one of the largest ever to name a U.S. inpatient hospital building.
Health companies return $2.6 trillion to shareholders over time amid rising medical costs Penn In the News USA Today Health companies return $2.6 trillion to shareholders over time amid rising medical costs A study led by Victor Roy of the Perelman School of Medicine finds that consumers and employers ultimately contributed to corporate health profits by paying for insurance premiums, out-of-pocket medical bills, and taxes. Jonathan A. Epstein named head of Perelman School of Medicine and Penn Health System Image: Margo Reed Jonathan A. Epstein named head of Perelman School of Medicine and Penn Health System Epstein has served as interim EVP and interim dean since December 2023. CAR T-cell therapy could help prevent clogged arteries Penn In the News New Scientist CAR T-cell therapy could help prevent clogged arteries Robert Schwab of the Perelman School of Medicine says that, if statins worked perfectly, cardiovascular disease wouldn’t remain the leading cause of death worldwide. No evidence that CAR T cell therapy causes secondary cancers Image: Courtesy of Penn Medicine No evidence that CAR T cell therapy causes secondary cancers In a new study, researchers at Penn Medicine looked for—and did not find—examples where the process of generating CAR T cells caused malignancy. Load More
Jonathan A. Epstein named head of Perelman School of Medicine and Penn Health System Image: Margo Reed Jonathan A. Epstein named head of Perelman School of Medicine and Penn Health System Epstein has served as interim EVP and interim dean since December 2023.
CAR T-cell therapy could help prevent clogged arteries Penn In the News New Scientist CAR T-cell therapy could help prevent clogged arteries Robert Schwab of the Perelman School of Medicine says that, if statins worked perfectly, cardiovascular disease wouldn’t remain the leading cause of death worldwide. No evidence that CAR T cell therapy causes secondary cancers Image: Courtesy of Penn Medicine No evidence that CAR T cell therapy causes secondary cancers In a new study, researchers at Penn Medicine looked for—and did not find—examples where the process of generating CAR T cells caused malignancy.
No evidence that CAR T cell therapy causes secondary cancers Image: Courtesy of Penn Medicine No evidence that CAR T cell therapy causes secondary cancers In a new study, researchers at Penn Medicine looked for—and did not find—examples where the process of generating CAR T cells caused malignancy.